All abstracts in PDF format (right click and "Save link as...")
SPEAKER SESSIONS
POSTER SESSIONS
-
Basic Science
- p52 Etiology, genetics, epidemiology, and toxicants
- p59 Cell death, neuroprotection and trophic factors
- p63 Protein misfolding and handling
- p65 Mitochondria, oxidative stress, inflammation, pathogen
- p68 Pathology
- p69 Animal and cellular models of Parkinsonisms
- p77 Brain physiology and circuitry
- p78 Dopamine, receptors and other neurotransmitters
- p79 Neuropharmacology
- p80 Electrophysiology & functional imaging, optogenetics
- p84 Prevention, neuroprotection neuroplasticity
-
Care Delivery & Quality of Life
- p86 Caregiving, relationships, respite care, families
- p90 Fitness, wellness, nutrition
- p98 Creativity & Alternative or complementary therapies
- p107 Lay/Professional health literacy & Public thought
- p109 Disability and quality of life outcome measures
- p111 Shared decision-making: PwP – caregiver – doctor
- p113 Palliative care/End of life care/Long-term care
- p114 Health accessibility/Underserved populations
- p119 Daily life activities including working & driving
- p119 Self-management, empowerment, coping strategies
- p124 Pharmacy and/or social work
-
Clinical Sciences
- p126 Symptoms, signs, features & non-motor manifestations
- p139 Progression and prognosis
- p141 Behavioral disorders
- p142 Cognition/mood/memory
- p149 Sleep disorders/fatigue
- p152 Diagnosis (differential, accuracy)
- p153 Co-morbidities
- p156 Biomarkers and neuroimaging
- p163 Pharmacology therapy
- p174 Surgical therapy, including cell and gene therapy
- p180 Rehabilitation sciences (PT, OT, SLP)
- p206 Complications of therapies
- p209 Clinical trials: design, outcomes, recruiting, etc.
- p219 Rating scales
- p220 E-health and technology
-
Living with Parkinson's
LATE-BREAKING ABSTRACTS
-
Basic Science
- p259 Etiology, genetics, epidemiology, and toxicants
- p259 Cell death, neuroprotection and trophic factors
- p260 Protein misfolding and handling
- p260 Mitochondria, oxidative stress, inflammation, pathogenesis
- p261 Animal & cellular models of Parkinson’s disease & Parkinsonisms
- p262 Brain physiology and circuitry
-
Care Delivery & Quality of Life
-
Clinical Sciences
- p264 Symptoms, signs, features, & non-motor manifestations
- p265 Diagnosis (differential, accuracy)
- p266 Biomarkers and neuroimaging
- p266 Pharmacology therapy
- p268 Surgical therapy, including cell and gene therapy
- p268 Rehabilitation sciences (PT, OT, SLP)
- p269 Clinical trials: design, outcomes, recruiting, etc.
-
Living with Parkinson's